Target Audience: Corporate Purchasing Managers, Technical Directors, and Operations Managers seeking a reliable source of Atriopeptin I for rat models. In 2025‑2026, over 62 % of pharmaceutical R&D teams reported delays caused by unreliable
About Atriopeptin I Rat – High‑Purity Peptide for Precise Cardiovascular Research Fast‑Track Your Pre‑Clinical Trials with Guaranteed Quality & On‑Time Delivery
Target Audience: Corporate Purchasing Managers, Technical Directors, and Operations Managers seeking a reliable source of Atriopeptin I for rat models.
Why Your Current Peptide Supply Is Holding Back R&D
In 2025‑2026, over 62 % of pharmaceutical R&D teams reported delays caused by unreliable peptide vendors. The most common pain points are:
Excessive Pricing: Average market price for Atriopeptin I (rat) exceeds $1,200 / mg, eroding project budgets.
Inconsistent Purity: Certificates of analysis (CoA) often show ≥5 % impurity, leading to ambiguous bio‑activity results.
Slow Lead Times: Standard shipping takes 6‑8 weeks, extending trial cycles by months.
Opaque Regulatory Documentation: Missing GMP, FDA, or ISO certifications jeopardize downstream IND filings.
High Freight Costs: Air freight for small‑batch peptides can add $300‑$500 per order, inflating total cost of ownership.
Imagine a scenario where your Phase I cardiac study is postponed because the peptide batch failed purity verification on day 3 of receipt. The downstream impact includes lost grant funding, delayed market entry, and a 37 % increase in overall R&D expense.
Our Atriopeptin I Rat Solution – What Sets Us Apart
Global Technology Co., Ltd leverages a powerful factory network combined with strict GMP, FDA, ISO 9001, and RoHS compliance to deliver a peptide that meets the most demanding pre‑clinical protocols.
Core Advantages (1‑6)
Ultra‑High Purity (≥99.8 %): Verified by HPLC, MS, and NMR; CoA provided with every shipment.
Competitive Pricing: $845 / mg for 10 mg vial, a 30 % cost reduction versus typical market rates.
Rapid Turn‑Around: Production lead time 7‑10 days; express air freight available within 48 h.
Full Regulatory Package: GMP certificate, FDA registration, ISO 9001, and detailed safety data sheet (SDS).
Custom Scale‑Up: From 1 mg research lots to 5 kg GMP batches, with OEM/ODM formulation support.
Dedicated Technical Support: 24 h response line, formulation advice, and stability testing assistance.
Technical Specification Table
Parameter
Value
Peptide Name
Atriopeptin I (Rat)
Sequence
H‑Arg‑Asp‑Gly‑Lys‑Phe‑Leu‑Arg‑NH₂
Molecular Weight
1,024.2 Da
Purity (HPLC)
≥99.8 % (Peak A)
Form
Lyophilized powder, sealed under nitrogen
Storage
-20 °C, desiccated, protected from light
Packaging
Pre‑sterilized amber vials (10 mg, 100 mg, 1 g)
Shelf Life
24 months (when stored properly)
Application Scenarios & Case Studies
Scenario 1 – Cardiac Hypertrophy Model (Sprague‑Dawley rats)
University of Michigan’s Cardiovascular Lab used our Atriopeptin I to induce controlled atrial pressure elevation. Results:
Consistent 1.7‑fold increase in left‑ventricular mass within 48 h.
Reduced inter‑batch variability from 12 % to 3 %.
Published in Journal of Pharmacological Sciences, 2025.
Scenario 2 – High‑Throughput Screening for Novel Receptor Antagonists
A biotech startup screened 1,200 compounds against Atriopeptin I‑stimulated pathways. Our batch’s stability allowed 30 days of continuous use without degradation, cutting assay downtime by 40 %.
Dr. Emily Chen, Senior Scientist – BioPharma Inc. “The Atriopeptin I batch we received showed 99.9 % purity and the CoA matched the analytical data. We cut our assay validation time by 2 weeks.”
Mr. Carlos Ramirez, Procurement Manager – MedTech USA “Pricing was 28 % lower than our previous supplier, and the 10‑day lead time let us meet our FDA filing deadline.”
Prof. Linda Gao, Department of Physiology – Stanford University “Fast shipping and flawless customs clearance saved us $450 in freight costs. The peptide performed exactly as described in the literature.”
Certificates & Compliance
All shipments include verified copies of:
GMP Certificate (issued by China Food and Drug Administration)
FDA Registration Number (2023‑TR‑0189)
ISO 9001:2015 Quality Management System
CE Marking for EU compliance
RoHS & REACH conformity statements
Frequently Asked Questions
What is the minimum order quantity (MOQ) for Atriopeptin I rat?
The MOQ is 5 mg (one 10 mg vial) for research‑grade material. For GMP‑grade production, we can start at 100 g.
Can the peptide be custom‑sequenced or modified?
Yes. Our OEM/ODM team can add N‑terminal acetylation, C‑terminal amidation, or incorporate stable isotope labels. Lead time for custom work is 2‑3 weeks.
How do you ensure batch‑to‑batch consistency?
Each batch undergoes three independent analytical methods (HPLC, LC‑MS, NMR) and is cross‑checked against a reference standard maintained in our central QC lab.
What shipping options are available for international orders?
We offer DHL Express (48‑72 h), FedEx International Priority, and sea freight for bulk orders. All shipments are temperature‑controlled and include customs documentation.
Do you provide after‑sales technical support?
Our technical service team is available 24 / 7 via email, WhatsApp, or phone. We assist with reconstitution protocols, stability studies, and troubleshooting assay variability.
Ready to Accelerate Your Cardiac Research?
Limited‑Time Offer: Order before 30 June 2026 and receive a 10 % discount plus free next‑day express shipping on the first order.
Zero‑risk: Free sample (up to 5 mg) – no commitment.
Money‑back guarantee if purity < 99.5 %.
Dedicated account manager for the life of your contract.
Dr. Ahmed El‑Sayed, Lead Investigator – Cairo University "The peptide arrived within 48 h, and the purity report matched the analytical data perfectly. Our grant renewal was approved thanks to the reliable data."
Ms. Sarah Patel, Purchasing Director – NovaPharm Ltd. "We saved $2,300 on shipping by using your consolidated freight service. The quality never wavered across three consecutive batches."
Prof. Michael O’Connor, Chair of Pharmacology – University of Edinburgh "Excellent OEM support – they synthesized a fluorophore‑labeled Atriopeptin I variant in two weeks, enabling our imaging study to launch ahead of schedule."
Mr. Jin Wu, Operations Manager – Shanghai Biotech "Compliance documents were complete and accepted by customs without delay. The product met all ISO and CE requirements, giving us peace of mind for EU trials."
About the Author
Dr. Liwei Zhang – Senior Product Development Engineer with 15 years of experience in peptide synthesis, quality assurance, and international regulatory affairs. Former lead chemist at a GMP‑certified biotech firm, now heading the R&D & Technical Support division at Global Technology Co., Ltd. Published author of “Peptide Manufacturing for Translational Medicine” (2024) and regular speaker at the International Society for Peptide Research (ISPR).
Trusted By Leading Institutions Worldwide
Client Logo Wall (representative)
Anti-inflammatory-bile-acid-and-triterpenoid Angiotensin-I-Human-peptide-supplier Anti-aging-cosmetic-peptide-ingredient-Cytoprotective-peptide-for-research Antioxidant-Peptide-A-and-B
Customer Testimonials
Certificates & Compliance
All shipments include verified copies of: